Ms. Sylvia Bartel is currently the Vice President of Pharmacy and Clinical Support at the Dana-Farber Cancer Institute in Boston, Massachusetts. She is also Adjunct Instructor of Clinical Pharmacy at Massachusetts College of Pharmacy and Allied Health.
Ms Bartel received her Bachelor of Science degree in Pharmacy at the University of Wisconsin and earned a Master of Science degree in Public Health from Northeastern University. She completed a pharmacy residency at the National Institutes of Health (NIH) in Bethesda, Maryland. After her residency, she practiced in oncology at the NIH and later at the Dana-Farber Cancer Institute.
Ms Bartel is a member of several professional organizations, including the Medication Error Prevention Consensus Group of the Massachusetts Coalition for the Prevention of Medical Errors and the American Society of Health-System Pharmacists. She also serves on the Professional Advisory Committee of Pediatric Homecare of America.
Ms Bartel has contributed articles to the medical literature on topics related to oncology and therapeutic guideline development. Her professional honors include being recipient of both the Abbott Laboratories National Hospital Pharmacy Quality Award and the Partners in Excellence Award from the Partners HealthCare System in Boston. She has given numerous presentations on the safe and appropriate handling of chemotherapy agents.

Niesha Griffith, MS, RPh, FASHP is Director of Pharmacy Services and Residency Program Director for the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and Associate Director of Pharmacy and Residency Program Coordinator (M.S. in Health-System Pharmacy Administration Residency Program) at The Ohio State University Medical Center. She graduated from the OSU College of Pharmacy in 1996 from the combined Masters in Hospital Pharmacy Administration/Residency Program. Niesha earned her B.S. in Pharmacy from West Virginia University in 1989. She holds an appointment of Clinical Assistant Professor at the OSU College of Pharmacy, where she is a member of the Division of Pharmacy Practice and Administration.

Ms. Griffith is responsible for planning, developing, evaluating, and improving pharmaceutical care for inpatients and outpatients of the 160 bed Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. This includes management of four outpatient chemotherapy infusion pharmacies, inpatient and outpatient clinical pharmacy services, and educational and research programs. She has been successful in the development of programs and services aimed at improving supportive care management of patients, ensuring appropriate and safe use of medications, maximizing medication reimbursement, and improving patient through-put. Under her leadership, hematology/oncology clinical services have expanded in both the inpatient and outpatient areas, and the James Pharmacy Program has earned national recognition for its efforts improving the use of supportive care and oral chemotherapy agents.